Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Jul-24 5:47 PM View:  | Revance Therapeutics, Inc. (RVNC) | 30-Jun-24 | Grant | 1,000 | $2.18 | $2,184.50 | < 1% 192.67K to 193.67K | |
| 19-Mar-24 6:44 PM View: | Revance Therapeutics, Inc. (RVNC) | 18-Mar-24 | Sale | 9,361 | $5.04 | $47,203.80 | (5%) 202.03K to 192.67K | |
| 19-Mar-24 6:44 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-24 | Payment of Exercise | 3,822 | $5.30 | $20,275.70 | (2%) 205.85K to 202.03K | |
| 04-Mar-24 4:44 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Feb-24 | Grant | 17,447 | -- | -- | 9% 188.4K to 205.85K | |
| 02-Feb-24 4:46 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Jan-24 | Grant | 96,667 | -- | -- | 105% 91.73K to 188.4K | |
| 03-Jan-24 4:48 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-23 | Grant | 434 | $7.47 | $3,241.98 | < 1% 91.3K to 91.73K | |
| 15-Aug-23 4:16 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Aug-23 | Grant | 22,620 | -- | -- | 28% 79.9K to 102.52K | |
| 15-Aug-23 4:16 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Aug-23 | Payment of Exercise | 11,215 | $18.91 | $212,076.00 | (11%) 102.52K to 91.3K | |
| 05-Jul-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 03-Jul-23 | Private Sale (Planned) | 1,701 | $25.04 | $42,593.00 | (2%) 81.6K to 79.9K | |
| 05-Jul-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-23 | Grant | 769 | $15.61 | $12,001.00 | < 1% 80.83K to 81.6K | (1%) |
| 05-Jun-23 6:06 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Jun-23 | Sale (Planned) | 500 | $31.00 | $15,500.00 | (< 1%) 81.33K to 80.83K | |
| 05-Jun-23 6:06 PM View: | Revance Therapeutics, Inc. (RVNC) | 01-Jun-23 | Private Sale (Planned) | 2,701 | $30.57 | $82,569.60 | (3%) 84.03K to 81.33K | |
| 16-May-23 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-May-23 | Sale | 21,401 | $34.55 | $739,338.00 | (20%) 105.43K to 84.03K | |
| 02-May-23 4:01 PM View: | Revance Therapeutics, Inc. (RVNC) | 01-May-23 | Private Sale (Planned) | 3,201 | $31.70 | $101,472.00 | (5%) 66.28K to 63.08K | |
| 04-Apr-23 4:24 PM View: | Revance Therapeutics, Inc. (RVNC) | 03-Apr-23 | Private Sale (Planned) | 3,201 | $32.15 | $102,912.00 | (5%) 69.48K to 66.28K | |
| 17-Mar-23 3:21 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-23 | Payment of Exercise | 3,739 | $30.65 | $114,600.00 | (5%) 73.22K to 69.48K | |
| 09-Mar-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Mar-23 | Sale | 18,517 | $31.59 | $584,884.00 | (20%) 91.74K to 73.22K | |
| 02-Mar-23 9:25 PM View: | Revance Therapeutics, Inc. (RVNC) | 01-Mar-23 | Private Sale (Planned) | 3,201 | $33.50 | $107,234.00 | (6%) 52.59K to 49.39K | |
| 16-Feb-23 8:28 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-23 | Payment of Exercise | 2,085 | $33.21 | $69,242.90 | (4%) 54.68K to 52.59K | |
| 02-Feb-23 9:38 PM View: | Revance Therapeutics, Inc. (RVNC) | 01-Feb-23 | Private Sale (Planned) | 3,201 | $34.60 | $110,755.00 | (6%) 57.88K to 54.68K | |
| 23-Jan-23 5:35 PM View: | Revance Therapeutics, Inc. (RVNC) | 20-Jan-23 | Private Sale (Planned) | 1,000 | $31.00 | $31,000.00 | (2%) 58.88K to 57.88K | |
| 10-Jan-23 8:06 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Jan-23 | Private Sale (Planned) | 3,701 | $27.16 | $100,525.00 | (6%) 62.58K to 58.88K | |
| 03-Jan-23 4:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-22 | Grant | 645 | $12.18 | $7,856.42 | 1% 61.93K to 62.58K | |
| 16-Dec-22 4:12 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-22 | Payment of Exercise | 1,557 | $21.50 | $33,475.50 | (2%) 63.49K to 61.93K | |
| 09-Mar-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-Sep-22 | Grant | 42,349 | -- | -- | 86% 49.39K to 91.74K | |
| 05-Jul-22 6:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-22 | Grant | 965 | $11.75 | $11,335.90 | 2% 62.52K to 63.49K | |
| 17-Mar-22 5:48 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-22 | Payment of Exercise | 2,607 | $15.79 | $41,164.50 | (4%) 65.13K to 62.52K | 2% |
| 17-Feb-22 8:49 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-22 | Payment of Exercise | 2,924 | $13.35 | $39,035.40 | (4%) 68.06K to 65.13K | |
| 16-May-23 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-22 | Grant | 42,349 | -- | -- | 67% 63.08K to 105.43K | |
| 04-Jan-22 8:58 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-21 | Acquisition (other) | 404 | $13.87 | $5,604.29 | < 1% 67.65K to 68.06K | |
| 17-Dec-21 5:31 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-21 | Payment of Exercise | 1,556 | $15.92 | $24,771.50 | (2%) 69.21K to 67.65K | (< 1%) |
| 02-Jul-21 7:53 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-21 | Acquisition (other) | 446 | $24.09 | $10,743.70 | < 1% 68.76K to 69.21K | |
| 19-Feb-21 8:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-21 | Payment of Exercise | 2,657 | $28.97 | $76,973.30 | (4%) 71.42K to 68.76K | 3% |
| 04-Feb-21 9:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-21 | Grant | 22,620 | -- | -- | 46% 48.8K to 71.42K | |
| 04-Jan-21 8:02 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-20 | Acquisition (other) | 493 | $21.36 | $10,530.70 | 1% 48.31K to 48.8K | |
| 22-Dec-20 8:39 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-20 | Payment of Exercise | 1,556 | $26.75 | $41,623.00 | (3%) 49.86K to 48.31K | (3%) |
| 02-Oct-20 8:32 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Grant | 15,750 | -- | -- | 40% 39.56K to 55.31K | |
| 02-Oct-20 8:32 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Payment of Exercise | 5,446 | $25.14 | $136,912.00 | (10%) 55.31K to 49.86K | (10%) |
| 02-Jul-20 8:18 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-20 | Acquisition (other) | 763 | $13.80 | $10,526.00 | 2% 38.8K to 39.56K | |
| 19-Feb-20 8:21 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Feb-20 | Payment of Exercise | 576 | $25.33 | $14,590.10 | (1%) 39.37K to 38.8K | (9%) |
| 24-Jan-20 8:21 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Jan-20 | Grant | 16,500 | -- | -- | 72% 22.87K to 39.37K | |
| 03-Jan-20 6:42 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-19 | Acquisition (other) | 504 | $10.82 | $5,453.28 | 2% 22.37K to 22.87K | 1% |
| 17-Dec-19 7:57 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Dec-19 | Payment of Exercise | 1,556 | $15.99 | $24,880.40 | (7%) 23.92K to 22.37K | (73%) |
| 02-Jul-19 9:16 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Jun-19 | Acquisition (other) | 923 | $11.02 | $10,175.60 | 4% 23.0K to 23.92K | (< 1%) |
| 25-Jan-19 9:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 24-Jan-19 | Grant | 5,000 | -- | -- | 28% 18.0K to 23.0K | |
| 07-Nov-18 8:31 PM View: | Revance Therapeutics, Inc. (RVNC) | 05-Nov-18 | Grant | 18,000 | -- | -- | 100% 0 to 18.0K | |
| 28-Jun-18 4:20 PM View: | Achaogen, Inc. (AKAO) | 26-Jun-18 | Grant | 860 | -- | -- | 2% 47.19K to 48.05K | |
| 28-Jun-18 4:20 PM View: | Achaogen, Inc. (AKAO) | 26-Jun-18 | Market Sale | 298 | $9.59 | $2,857.82 | (< 1%) 48.05K to 47.75K | 90% |
| 13-Jun-18 5:03 PM View: | Achaogen, Inc. (AKAO) | 11-Jun-18 | Market Sale | 2,087 | $11.95 | $24,939.70 | (4%) 49.27K to 47.19K | 92% |
| 23-Feb-18 8:38 PM View: | Achaogen, Inc. (AKAO) | 21-Feb-18 | Market Sale | 1,108 | $10.67 | $11,822.40 | (3%) 41.29K to 40.19K | 91% |